CytoDyn Inc.
CYDY- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001175680
No open-market purchases or sales by CytoDyn Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $35.2K in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in CytoDyn Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −4 vs. Q2 2021
- Shares held
- 606.9K
- −231.0K (−27.6%) vs. Q2 2021
- Total value
- $1.21M
- −$220.0K (−15.4%) vs. Q2 2021
- New holders
- 1
- 2 more added
- Sold out
- 5
- 3 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CYDY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 6 | $35.2K |
| Q1 2026 | 9 | $87.1K |
| Q4 2025 | 8 | $91.0K |
| Q3 2025 | 11 | $120.5K |
| Q2 2025 | 11 | $76.4K |
| Q1 2025 | 11 | $64.7K |
| Q4 2024 | 10 | $29.8K |
| Q3 2024 | 9 | $64.6K |
| Q2 2024 | 11 | $37.4K |
| Q1 2024 | 12 | $47.9K |
| Q4 2023 | 11 | $92.5K |
| Q3 2023 | 9 | $41.2K |
| Q2 2023 | 12 | $146.5K |
| Q1 2023 | 11 | $162.5K |
| Q4 2022 | 12 | $110.8K |
| Q3 2022 | 13 | $315.0K |
| Q2 2022 | 13 | $208.3K |
| Q1 2022 | 16 | $191.5K |
| Q4 2021 | 18 | $568.8K |
| Q3 2021 | 16 | $1.21M |
| Q2 2021 | 20 | $1.43M |
| Q1 2021 | 21 | $2.11M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding CytoDyn Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Firsthand Capital Management, Inc. | 222,730 | $441.0K | 0.13% | 00.0% | Unchanged |
| Capital Advantage, Inc. | 91,000 | $180.0K | 0.05% | 00.0% | Unchanged |
| L & S Advisors Inc | 50,600 | $100.0K | 0.01% | 00.0% | Unchanged |
| Diversified Trust Co | 45,790 | $91.0K | 0.00% | 00.0% | Unchanged |
| Next Capital Management LLC | 37,500 | $74.0K | 0.05% | +37,500 | New |
| Captrust Financial Advisors | 28,626 | $57.0K | 0.00% | +3,751+15.1% | Added |
| Moloney Securities Asset Management, LLC | 27,025 | $54.0K | 0.01% | −1,250−4.4% | Reduced |
| MAI Capital Management | 25,000 | $50.0K | 0.00% | 00.0% | Unchanged |
| S.A. Mason LLC | 19,000 | $38.0K | 0.03% | 00.0% | Unchanged |
| Hollencrest Capital Management | 17,000 | $34.0K | 0.00% | −21,500−55.8% | Reduced |
| FineMark National Bank & Trust | 15,000 | $30.0K | 0.00% | +5,000+50.0% | Added |
| Inverness Counsel LLC | 10,000 | $20.0K | 0.00% | 00.0% | Unchanged |
| Ancora Advisors, LLC | 9,488 | $19.0K | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 4,150 | $9.00K | 0.00% | −5,124−55.3% | Reduced |
| Caz Investments LP | 4,000 | $8.00K | 0.01% | 00.0% | Unchanged |
| Holloway Wealth Management, LLC | – | $7.00K | 0.00% | – | – |
| Fairfield, Bush & Co. | 0 | $0 | 0.00% | −155,109−100.0% | Sold out |
| Willis Investment Counsel | 0 | $0 | 0.00% | −87,237−100.0% | Sold out |
| McCarthy Asset Management, Inc. | 0 | $0 | 0.00% | −4,300−100.0% | Sold out |
| Tradition Wealth Management, LLC | 0 | $0 | 0.00% | −2,697−100.0% | Sold out |
| Dividend Assets Capital, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |